ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA
Clinical trials for ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for minority patients with advanced stomach or esophageal cancer?
Disease control Recruiting nowThis study is testing a drug called tislelizumab combined with chemotherapy as a first treatment for people with advanced stomach or esophageal cancer that cannot be removed by surgery or has spread. It focuses on racial and ethnic minority groups in the US, including Black, Hisp…
Matched conditions: ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New immune cocktail targets tough stomach cancers
Disease control Recruiting nowThis study tests a mix of immune cells (agenT-797) and three immunotherapy drugs (botensilimab, balstilimab, ramucirumab) plus chemotherapy (paclitaxel) for people with advanced stomach, esophageal, or gastro-esophageal junction cancer that has worsened after one prior treatment.…
Matched conditions: ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC